SBI Investment — 2019 Investments
3 investments dated 2019 · listed companies and verified rows first · show all
A company that manufactures mass spectrometry instruments for semiconductor and freeze-drying process monitoring and control at the molecular level.
Advanced ManufacturingAI & Machine LearningDeep TechHardwareSemiconductorsTokyo, JP
Sridhar Marcy Prakash(Founder, President and CEO)
Co-investorsCelesta CapitalGlobal Hands-On VCOpen Field CapitalINCJ, Ltd.Japan Post Investment
Satsuma Pharmaceuticals develops therapeutics for the acute treatment of migraine, including an approved dihydroergotamine nasal powder product (Atzumi/STS101).
BiotechHealthtechMedical DevicesSouth San Francisco, US
John Kollins(Executive Officer, Director)Tadayoshi Iwashima(Executive Officer)Thomas B. King(President and Board Director)inRob Janosky(Chief Commercial Officer)Tom O'Neil(Chief Financial Officer)inDavid Prichard(Chief Operating Officer)
Co-investorsOUP (Osage University Partners)Vivo CapitalWellington ManagementLumira VenturesRA CapitalRed Tree Venture
Japanese end-of-life services company that connects bereaved families to funeral homes and Buddhist monk-dispatch services online.
Tokyo, JP
芦沢 雅治(代表取締役 (Representative Director))Masaharu Ashizawain篠﨑 新悟(代表取締役 (Representative Director))
Co-investorsAG Capital Co. Ltd.Global BrainGlobis Capital PartnersSony Ventures CorporationAG CapitalCygames Capital+5 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.











